ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,400,000 | +8.2% | 2,500,000 | -41.9% | 0.40% | -21.8% |
| Q4 2018 | $6,837,000 | -7.1% | 4,300,000 | +115.0% | 0.52% | +17.2% |
| Q3 2018 | $7,360,000 | -35.0% | 2,000,000 | -50.0% | 0.44% | -40.2% |
| Q2 2018 | $11,320,000 | -29.0% | 4,000,000 | -6.9% | 0.74% | -39.4% |
| Q1 2018 | $15,938,000 | +248.0% | 4,296,000 | +321.2% | 1.22% | +125.7% |
| Q3 2017 | $4,580,000 | – | 1,020,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |